Field Trip will make its trading debut on Tuesday.
MindMed Partners with NYU Langone Medical Center to Launch Groundbreaking Training Program for Psychedelic Therapies and Medicines
This is MindMed's first step in establishing a Center for Psychedelic Medicine at NYU Langone Health.
Field Trip Psychedelics RTO Provides Exciting New Investing Option
Field Trip Psychedelics is targeting a $16 billion treatment market with its ketamine-assisted psychotherapy clinics.
Field Trip Health Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange
Field Trip to commence trading October 7th on the CSE, symbol "FTRP".
Mind Cure (CSE: MCUR) Adds World-Renowned Psychedelic Researcher To Advisory Board
Dr. Dan Engle, a leading voice in psychedelic medicine, has been appointed by Mind Cure (CSE:MCUR) as a scientific advisor
Dr. Dan Engle Joins Mind Cure's (CSE: MCUR) Advisory Board
The world-renowned transformative medicine expert will contribute towards Mind Cure's work in the realm of psychedelic research, treatment and integration
Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development
Field Trip announces testing of its first synthesized psychedelics molecule.
Mind Cure Adds Two-Time Female Entrepreneur of The Year As New COO
Mind Cure's new Chief Operating Officer has already launched several successful businesses.
Mind Cure Adds High-Profile Female As New COO
Mind Cure's new Chief Operating Officer has already launched several successful businesses.
Mind Cure (CSE: MCUR) Announces Kelsey Ramsden as new Chief Operating Officer
The company bolsters its executive team with the addition of an industry leader and experienced entrepreneur
Will MindMed Be The Next Billion-Dollar Psychedelic Stock?
With trading volumes going through the roof and a potential NASDAQ listing, will MindMed be the next billion-dollar psychedelics company?
The Three Hottest Psychedelic Stocks That Every Investor Should Research
Psychedelic stocks have exploded on news of the Compass Pathways IPO. Three companies are leading the charge.
